Tag: resistant hypertension
SoniVie receives FDA IDE approval for pilot study to treat hypertension with renal artery denervation TIVUS technology
SoniVie recently announced that on 5 May 2022 the US Food and Drug Administration (FDA) granted inve...
First patients enrolled in trial of MobiusHD for drug-resistant hypertension
Vascular Dynamics has revealed that enrolment of the first patients in an FDA-approved and best-...
ESC 2017: MobiusHD implant shown to reduce resistant hypertension
The European results of the first-in-human trial of Vascular Dynamics’ MobiusHD implant indicate...
